[Lipids and apolipoproteins A1 and B alterations in stroke].
The purpose of this case-control study was to determine the variations of lipoproteins during stroke in adults from Ivory Coast. The survey included 72 subjects presenting with hemorrhagic stroke and 58 of ischemic stroke, aged of 25 at 93 years. Lipids parameters have been measured by a colorimetric enzymatic method. Apolipoproteins have been determined by immunoturbidimetry. Results showed significant decrease of HDL-cholesterol and apoprotein A1 in patients by comparison with control subjects. More over, an increase of the atherogenicity index expressed as total/HDL-cholesterol or apolipoprotein B /apolipoprotein A1, of the triglycerides and apolipoprotein B has been observed.
Edjeme-Ake
A
A
Laboratoire de biochimie, UFR de sciences pharmaceutiques et biologiques, Abidjan, Côte d'Ivoire, France.
Yapi Houphouet
F
F
Hauhouot-Attoungbre
M L
ML
N'Guessan
A M C
AM
Attofouet
A S
AS
Kouassi
B
B
Monnet
D
D
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016632:Apolipoprotein A-I / Q000097:blood*; D001055:Apolipoproteins B / Q000097:blood*; D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020521:Stroke / Q000097:blood*
D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D002784:Cholesterol